Compare Adaptive Biotechnologies Corp (ADPT) vs Capri Holdings Ltd (CPRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Capri Holdings Ltd — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while Capri Holdings Ltd trades at $15.62 (market cap $1.75B). The key difference: Adaptive Biotechnologies Corp is far larger — about 2.3× Capri Holdings Ltd's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Capri Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| ADPT | CPRI | |
|---|---|---|
Market Cap | $4.05B | $1.75B |
Sector | Health | Consumer Staples |
52-Week High | $25.45 | $27.66 |
52-Week Low | $12.30 | $14.98 |
Enterprise Value | $4.12B | $3.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Capri Holdings Ltd
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →
